Cara Therapeutics Presents Late-Breaking Results Of The KOMFORT Phase 2 Trial Of Oral Difelikefalin For Pruritus In Notalgia Paresthetica At The 31St EADV Congress

Press/Media

Period8 Sep 2022

Media coverage

73

Media coverage